Answer
Eplerenone is indicated in stable patients with left ventricular dysfunction (LVEF ≤40%) and clinical evidence of heart failure after recent myocardial infarction, in addition to standard therapy including beta-blockers, to reduce cardiovascular mortality and morbidity.
Sources for this answer
- Inspra 25 mg Film-coated TabletsViatris (formerly Mylan or Upjohn) · emc · SmPC §4.1 Therapeutic Indications · Version 17Document updated
Sources checked